• 1. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 2. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 3. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 4. Distinct correlation between (CN2)x units and pores: a low-cost method for predesigned wide range control of micropore size of porous carbon?
  Xiaotong Feng,Lei Bian,Jie Ma,Lei Zhou,Xiayan Wang,Guangsheng Guo,Qiaosheng Pu Chem. Commun., 2019,55, 3963-3966
• 5. Enantiomerically pure 1,3,2-dioxaborolanes: new reagents for the hydroboration of alkynes
  Chem. Commun., 1998, 2651-2652

Methyl 2,4-difluoro-6-methoxybenzoate (CAS No. 1534389-85-9): A Comprehensive Overview

Methyl 2,4-difluoro-6-methoxybenzoate, identified by its CAS number 1534389-85-9, is a fluorinated aromatic ester that has garnered significant attention in the field of pharmaceutical and chemical research. This compound, characterized by its unique structural features, exhibits a range of potential applications that span from medicinal chemistry to material science. The presence of both fluoro and methoxy substituents in its molecular framework imparts distinct chemical properties, making it a subject of extensive study and exploration.

The molecular structure of Methyl 2,4-difluoro-6-methoxybenzoate consists of a benzoate core substituted with two fluorine atoms at the 2- and 4-positions and a methoxy group at the 6-position. This specific arrangement contributes to its reactivity and interaction with biological systems. The fluoro groups, in particular, are known for their ability to modulate metabolic pathways and enhance binding affinity, which has been leveraged in the development of various therapeutic agents.

In recent years, the pharmaceutical industry has shown increasing interest in fluorinated compounds due to their improved pharmacokinetic profiles and metabolic stability. Methyl 2,4-difluoro-6-methoxybenzoate is no exception and has been investigated for its potential role in drug design. Its ability to act as a key intermediate in synthesizing more complex molecules has made it valuable in the development of novel treatments for various diseases.

One of the most compelling aspects of Methyl 2,4-difluoro-6-methoxybenzoate is its versatility in chemical transformations. The ester functionality allows for further derivatization, enabling researchers to create a diverse array of analogs with tailored properties. These derivatives can then be tested for their biological activity, leading to the discovery of new pharmacological entities.

The synthesis of Methyl 2,4-difluoro-6-methoxybenzoate typically involves multi-step organic reactions that require precise control over reaction conditions. Advanced synthetic methodologies have been employed to optimize yield and purity, ensuring that the final product meets the stringent requirements of pharmaceutical applications. Techniques such as palladium-catalyzed cross-coupling reactions and fluorination methods have been particularly useful in constructing the desired molecular framework.

Recent studies have highlighted the role of fluorinated benzoates in medicinal chemistry. For instance, derivatives of Methyl 2,4-difluoro-6-methoxybenzoate have been explored for their anti-inflammatory and anti-cancer properties. The fluoro groups enhance the lipophilicity of these compounds, improving their absorption and distribution within biological systems. Additionally, the methoxy group contributes to selective interactions with target enzymes and receptors, increasing the efficacy of these therapeutic agents.

The chemical properties of Methyl 2,4-difluoro-6-methoxybenzoate also make it a valuable tool in material science. Its ability to form stable complexes with other molecules has been utilized in the development of novel materials with enhanced functional properties. These materials find applications in areas such as catalysis, sensors, and advanced polymers.

In conclusion, Methyl 2,4-difluoro-6-methoxybenzoate (CAS No. 1534389-85-9) is a multifaceted compound with significant potential in both pharmaceuticals and materials science. Its unique structural features and chemical properties have positioned it as a key player in ongoing research efforts aimed at developing new treatments and innovative materials. As scientific understanding continues to evolve, it is likely that even more applications for this compound will be uncovered.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)